Treatment of Patients Suffering of Alcohol Dependence and Impaired Liver Function With Selincro® As-needed Use

NCT02197598 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Alcohol Dependence

Interventions

DRUG: nalmefene

Sponsor

H. Lundbeck A/S